OLBA HEALTHCARE HOLDINGS Valuation
Is 2689 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Earnings gegen Gleichaltrige
Price-To-Earnings gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of 2689 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: 2689 (¥1730) wird über unserer Schätzung des Fair Value (¥1441.52) gehandelt.
Deutlich unter dem Marktwert: 2689 über unserer Schätzung des beizulegenden Zeitwerts gehandelt wird.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 2689?
Other financial metrics that can be useful for relative valuation.
What is 2689's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | JP¥12.16b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.1x |
Enterprise Value/EBITDA | 4.6x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does 2689's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 14.8x | ||
3417 Ohki Healthcare HoldingsLtd | 5.8x | n/a | JP¥13.7b |
3079 DVx | 24.5x | n/a | JP¥9.7b |
7488 Yagami | 14.3x | n/a | JP¥16.5b |
3154 Medius Holdings | 14.6x | n/a | JP¥16.7b |
2689 OLBA HEALTHCARE HOLDINGS | 9x | n/a | JP¥12.2b |
Price-To-Earnings gegen Gleichaltrige: 2689 ist ein guter Wert, wenn man sein Price-To-Earnings Verhältnis (8.1x) mit dem Durchschnitt der anderen Unternehmen (15x) vergleicht.
Price to Earnings Ratio vs Industry
How does 2689's PE Ratio compare vs other companies in the JP Healthcare Industry?
Price-To-Earnings gegen Industrie: 2689 ist aufgrund seines Price-To-Earnings Verhältnisses (8.1x) im Vergleich zum JP Healthcare Branchendurchschnitt (15.9x) ein guter Wert.
Price to Earnings Ratio vs Fair Ratio
What is 2689's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 9x |
Fair PE Ratio | n/a |
PM vs. Fair Ratio: Unzureichende Daten zur Berechnung der Price-To-Earnings Fair Ratio von 2689 für die Bewertungsanalyse.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analysten-Prognose: Unzureichende Daten für eine Preisprognose.